ClinicalTrials.Veeva

Menu

The Immunomodulation Effect of Blood Transfusion in Operative Spine Surgery Patients

M

Mahidol University

Status

Unknown

Conditions

Infection After Transfusion

Treatments

Other: Blood transfusion

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to investigate the effect of transfusion of allogeneic (homologous) red cells on the immunologic parameters such as T-cells as well as natural killer cell count/function, various interleukins, TNF alpha and other immunologic relevant parameters on postoperative day 1,3 and 5-7 in patients undergoing spine surgery.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 18 - < 60 years
  • Patients underwent elective spine surgery
  • ASA classification 1-3

Exclusion criteria

  • Patients who have the concomitant condition
  • Cancer
  • History of heart disease including, heart failure, coronary artery disease, hypertension treated with more than one medicament.
  • Serum creatinine > 1.5 mg/dL
  • Stroke, neurologic and mental deficits, epilepsy
  • General or local infection (site of surgery),
  • Coagulation disorders.
  • Intraoperative massive bleeding
  • Infection of the spine
  • Rheumatoid arthritis
  • Patients who had either of the following drug (aspirin, methotrexate, cyclosporine, qualaquin)

Trial design

40 participants in 1 patient group

Blood transfusion
Description:
Patients receive blood transfusion during operation
Treatment:
Other: Blood transfusion

Trial contacts and locations

1

Loading...

Central trial contact

Sirilak Suksompong, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems